Mytos

Mytos is a company focused on automating the production of regenerative medicines, aiming to make these therapies accessible to millions of patients. Their primary product, the iDEM™ technology, serves as an automated Contract Development and Manufacturing Organization (CDMO) specifically designed for regenerative medicine. By leveraging this advanced automation, Mytos seeks to enhance the speed, scale, and efficiency of producing cell-based therapies, which are critical for treating conditions such as Parkinson's disease, blindness, and spinal cord injuries.

The iDEM technology automates all…